Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
SSE:605016
Price:
24.7
CNY
0.2%
Market Closed
Market Cap:
¥10.4B
Income Statement
Earnings Waterfall
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Income Statement
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Shandong Bailong Chuangyuan Bio-Tech Co Ltd
Currency: CNY
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
0
|
|
| Revenue |
717
N/A
|
739
+3%
|
732
-1%
|
722
-1%
|
719
0%
|
742
+3%
|
825
+11%
|
868
+5%
|
926
+7%
|
987
+7%
|
1 035
+5%
|
1 152
+11%
|
1 213
+5%
|
1 269
+5%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(502)
|
(523)
|
(505)
|
(494)
|
(503)
|
(503)
|
(559)
|
(585)
|
(637)
|
(672)
|
(707)
|
(767)
|
(796)
|
(808)
|
|
| Gross Profit |
215
N/A
|
217
+1%
|
226
+4%
|
227
+0%
|
215
-5%
|
239
+11%
|
266
+12%
|
283
+6%
|
289
+2%
|
315
+9%
|
327
+4%
|
385
+17%
|
417
+8%
|
462
+11%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(74)
|
(73)
|
(72)
|
(74)
|
(57)
|
(69)
|
(76)
|
(76)
|
(74)
|
(80)
|
(79)
|
(116)
|
(111)
|
(122)
|
|
| Selling, General & Administrative |
(53)
|
(45)
|
(46)
|
(53)
|
(37)
|
(51)
|
(52)
|
(53)
|
(51)
|
(58)
|
(61)
|
(74)
|
(75)
|
(83)
|
|
| Research & Development |
(27)
|
(32)
|
(31)
|
(24)
|
(30)
|
(27)
|
(31)
|
(29)
|
(33)
|
(37)
|
(33)
|
(41)
|
(46)
|
(49)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
|
| Other Operating Expenses |
6
|
4
|
5
|
8
|
10
|
9
|
7
|
13
|
11
|
16
|
16
|
10
|
10
|
9
|
|
| Operating Income |
142
N/A
|
144
+2%
|
155
+7%
|
153
-1%
|
158
+3%
|
169
+7%
|
190
+12%
|
207
+9%
|
215
+4%
|
235
+9%
|
249
+6%
|
269
+8%
|
306
+14%
|
340
+11%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
6
|
8
|
14
|
23
|
23
|
23
|
18
|
17
|
18
|
16
|
15
|
16
|
15
|
14
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
(0)
|
(2)
|
(5)
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Total Other Income |
(2)
|
(1)
|
(1)
|
(0)
|
(5)
|
(6)
|
(6)
|
0
|
(1)
|
0
|
0
|
1
|
(0)
|
(0)
|
|
| Pre-Tax Income |
146
N/A
|
151
+3%
|
168
+11%
|
173
+3%
|
177
+3%
|
188
+6%
|
204
+8%
|
222
+9%
|
232
+5%
|
251
+8%
|
263
+5%
|
285
+8%
|
318
+11%
|
349
+10%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
(18)
|
(20)
|
(21)
|
(22)
|
(23)
|
(25)
|
(30)
|
(29)
|
(30)
|
(29)
|
(29)
|
(40)
|
(45)
|
(53)
|
|
| Income from Continuing Operations |
128
|
131
|
147
|
151
|
155
|
163
|
174
|
193
|
202
|
221
|
234
|
246
|
273
|
296
|
|
| Net Income (Common) |
128
N/A
|
131
+3%
|
147
+12%
|
151
+2%
|
155
+2%
|
163
+6%
|
174
+7%
|
193
+11%
|
202
+5%
|
221
+10%
|
234
+6%
|
246
+5%
|
273
+11%
|
296
+8%
|
|
| EPS (Diluted) |
0.3
N/A
|
0.31
+3%
|
0.34
+10%
|
0.36
+6%
|
0.36
N/A
|
0.38
+6%
|
0.41
+8%
|
0.46
+12%
|
0.48
+4%
|
0.52
+8%
|
0.57
+10%
|
0.58
+2%
|
0.65
+12%
|
0.7
+8%
|
|
Switch to:
Switch to:
See Also
Discover More
